G-]A SUBSTITUTION AT POSITION-75 OF THE APOLIPOPROTEIN-A-I GENE PROMOTER - EVIDENCE AGAINST A DIRECT EFFECT ON HDL CHOLESTEROL LEVELS

被引:39
作者
MINNICH, A
DELANGAVANT, G
LAVIGNE, J
ROEDERER, G
LUSSIERCACAN, S
DAVIGNON, J
机构
[1] Clin. Research Institute of Montreal, Montreal, Que.
[2] Clin. Research Institute of Montreal, Montreal, Que. H2W 1R7, 110 Pine Avenue, West
关键词
HYPERALPHALIPOPROTEINEMIA; GENETIC POLYMORPHISM; HDL CHOLESTEROL; APOA-I GENE;
D O I
10.1161/01.ATV.15.10.1740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study sought to resolve the contradictory evidence as to whether the G-->A substitution at position -75 of the apoA-I gene promoter raises HDL cholesterol (HDL-C) levels by examining the effect of this polymorphism in French Canadians, a relatively genetically homogeneous population. Among 308 women, carriers of the A allele displayed 12% and 10% higher mean plasma HDL-C and apoA-I concentrations, respectively, than did noncarriers. Among 345 men, no effect of the A allele was noted. The frequency distribution of HDL-C levers in women carrying the A but not the G allele appeared bimodal, with one peak corresponding to the mean of the noncarriers and a second to higher HDL-C. Thus it appears that only a subset of A alleles confers high HDLC levels. This hypothesis was supported by data from four kindreds within which some but not all A alleles segregated with hyperalphalipoproteinemia. The data suggest that the A substitution in the apoA-I gene promoter does not directly confer high HDL-C levers but may be in linkage disequilibrium with other sequence polymorphism(s) at this locus in a subset of alleles that raise HDL-C levels.
引用
收藏
页码:1740 / 1745
页数:6
相关论文
共 35 条
[1]  
ANGOTTI E, 1994, J BIOL CHEM, V269, P17371
[2]  
BARRE DE, 1994, J LIPID RES, V35, P1292
[3]   MOLECULAR GENETIC-EVIDENCE FOR A FOUNDER EFFECT IN FAMILIAL HYPERCHOLESTEROLEMIA AMONG FRENCH-CANADIANS [J].
BETARD, C ;
KESSLING, AM ;
ROY, M ;
CHAMBERLAND, A ;
LUSSIERCACAN, S ;
DAVIGNON, J .
HUMAN GENETICS, 1992, 88 (05) :529-536
[4]   HYPERVARIABLE POLYMORPHISM IN THE APOC3 GENE [J].
BHATTACHARYA, S ;
WILSON, TME ;
WOJCIECHOWSKI, AP ;
VOLPE, CP ;
SCOTT, J .
NUCLEIC ACIDS RESEARCH, 1991, 19 (17) :4799-4799
[5]   VARIATION AT THE HEPATIC LIPASE AND APOLIPOPROTEIN AI/CIII/AIV LOCI IS A MAJOR CAUSE OF GENETICALLY-DETERMINED VARIATION IN PLASMA HDL CHOLESTEROL LEVELS [J].
COHEN, JC ;
WANG, ZF ;
GRUNDY, SM ;
STOESZ, MR ;
GUERRA, R .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2377-2384
[6]   FAMILIAL HYPERCHOLESTEROLEMIA IN FRENCH-CANADIANS - TAKING ADVANTAGE OF THE PRESENCE OF A FOUNDER EFFECT [J].
DAVIGNON, J ;
ROY, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (10) :D6-D10
[7]  
DAY NE, 1969, BIOMETRIKA, V56, P463, DOI 10.1093/biomet/56.3.463
[8]   GENETIC EPIDEMIOLOGY OF AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY IN NORTHEASTERN QUEBEC [J].
DEBRAEKELEER, M ;
GIASSON, F ;
MATHIEU, J ;
ROY, M ;
BOUCHARD, JP ;
MORGAN, K .
GENETIC EPIDEMIOLOGY, 1993, 10 (01) :17-25
[9]   GENETIC EPIDEMIOLOGY OF SENSORIMOTOR POLYNEUROPATHY WITH OR WITHOUT AGENESIS OF THE CORPUS-CALLOSUM IN NORTHEASTERN QUEBEC [J].
DEBRAEKELEER, M ;
DALLAIRE, A ;
MATHIEU, J .
HUMAN GENETICS, 1993, 91 (03) :223-227
[10]   A FRAMESHIFT MUTATION IN THE HUMAN APOLIPOPROTEIN-A-I GENE CAUSES HIGH-DENSITY-LIPOPROTEIN DEFICIENCY, PARTIAL LECITHIN - CHOLESTEROL-ACYLTRANSFERASE DEFICIENCY, AND CORNEAL OPACITIES [J].
FUNKE, H ;
VONECKARDSTEIN, A ;
PRITCHARD, PH ;
KARAS, M ;
ALBERS, JJ ;
ASSMANN, G ;
RECKWERTH, A ;
WELP, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :371-376